Climb Bio, Inc. insider trading
CLYM$10.94-0.13 (-1.17%)
“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.”
Insider Trading vs Stock Price
Insider Trading vs Stock Price data
Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (+436.3%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.
| Date | Category | Person | Role | Action | Amount | Change in holding |
|---|
Open market purchase
Open market sellNet dollar flow · Buy / Sell balance
PremiumQ2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Unlock quarterly net flowKey players
- SBStephen Basil Thomas0.8148%
- ABAoife Brennan0.1527%
- EPEmily Pimblett0.0329%
- RCRA Capital Healthcare Fund LPNot reported
- RCRa Capital Management, L.P.Not reported
- PKPeter KolchinskyNot reported
AI Activity Analysis
PremiumComing soon
Insider activity
Fromto
| Company | Insider / role | Action | ΔOwn | Avg price | Amount | ||
|---|---|---|---|---|---|---|---|
| CLYM | Stephen Basil Thomas | Open market sell$1.37M | -17.6% | $13.67 | $1.37M | Sep 15, 2026 | Sep 17, 2026 |
| CLYM | Aoife Brennan | Open market sell$407K | -26.1% | $13.17 | $407K | Jun 29, 2026 | Jun 30, 2026 |
| CLYM | Stephen Basil Thomas | Open market sell$114K | -9.5% | $7.01 | $114K | Feb 26, 2026 | Feb 27, 2026 |
| CLYM | Stephen Basil Thomas | Open market sell$236K | -16.5% | $7.00 | $236K | Feb 25, 2026 | Feb 27, 2026 |
| CLYM | Stephen Basil Thomas | Open market sell$58.1K | -4.7% | $5.81 | $58.1K | Feb 13, 2026 | Feb 17, 2026 |
| CLYM | Stephen Basil Thomas | Open market sell$471K | -29.5% | $5.23 | $471K | Feb 12, 2026 | Feb 17, 2026 |
| CLYM | RA Capital Healthcare Fund LP | Open market purchase$24.9K | +0.2% | $3.50 | $24.9K | Jan 5, 2026 | Jan 7, 2026 |
| CLYM | Peter Kolchinsky | Open market purchase$290K | +3.1% | $2.86 | $290K | Dec 12, 2025 | Dec 15, 2025 |
| CLYM | Peter Kolchinsky | Open market purchase$465K | +6.9% | $2.18 | $465K | Dec 11, 2025 | Dec 15, 2025 |